DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BRONCHO SALINE

« Back to Dashboard

Clinical Trials for Broncho Saline

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00029328	Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation	Completed	FDA Office of Orphan Products Development	Phase 1/Phase 2	2001-09-01	The purpose of this study is to determine the effects of etanercept, and define the toxicity, when administered to patients with acute non-infectious lung injury (idiopathic pneumonia syndrome, IPS) and with subacute pulmonary dysfunction after allogeneic stem cell transplantation.
NCT00041561	Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) in Pediatrics	Terminated	Mallinckrodt	Phase 3	2002-01-01	The purpose of this study is to determine the effect of nitric oxide for inhalation on the duration of mechanical ventilation in pediatric patients with AHRF.
NCT00127985	6-Methyl-Prednisolone for Multiple Organ Dysfunction Syndrome	Unknown status	Pfizer	Phase 4	2005-08-01	Background: Systemic corticosteroids are considered in patients with an adverse clinical course suffering from conditions like the acute respiratory distress syndrome (ARDS) and septic shock. Treated patients not only show improved respiratory function, but also hemodynamic status and overall multiple organ dysfunction score. Objective: To evaluate the safety and effectiveness of 6-methyl-prednisolone on the clinical course of multiple organ dysfunction syndrome (MODS). Design: Multi-center, double-blind, randomized, placebo-controlled. Intervention: Intravenous administration of 6-methyl-prednisolone or placebo (aqueous solution). The duration of the study medication administration protocol is 32 days (1). Primary Endpoints: 1. All cause Intensive Care Unit (ICU) and 28-day mortality 2. Organ dysfunction score on days 4, 7, 14, and 28 of the protocol.

Clinical Trial Conditions for Broncho Saline

Condition Name

Condition Name for Broncho Saline
Intervention	Trials
Asthma	3
Cystic Fibrosis	2
Pneumonia	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Broncho Saline
Intervention	Trials
Syndrome	3
Pulmonary Disease, Chronic Obstructive	3
Pneumonia	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Broncho Saline

Trials by Country

Trials by Country for Broncho Saline
Location	Trials
United States	36
France	7
Spain	2
Belgium	2
Switzerland	2

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Broncho Saline
Location	Trials
New York	4
Maryland	3
Arizona	2
Georgia	2
Florida	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Broncho Saline

Clinical Trial Phase

Clinical Trial Phase for Broncho Saline
Clinical Trial Phase	Trials
Phase 4	7
Phase 3	4
Phase 2	7

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Broncho Saline
Clinical Trial Phase	Trials
Completed	12
Not yet recruiting	5
Recruiting	4

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Broncho Saline

Sponsor Name

Sponsor Name for Broncho Saline
Sponsor	Trials
Hospices Civils de Lyon	4
National Cancer Institute (NCI)	3
University of Lyon	2

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Broncho Saline
Sponsor	Trials
Other	30
Industry	10
NIH	4

Export unavailable in trial.
Subscribe for complete access.